Investors - Press Releases
|View printer-friendly version|
Dr Kristi Kuper Joins DoseMe as Director of Clinical Pharmacy
Dr. Kuper is a Board Certified Pharmacotherapy Specialist who has spent the last 20 years in a variety of clinical pharmacy leadership roles working with more than 500 hospitals. She has contributed to over 40 publications and has experience co-leading national research projects on under-researched areas in antibiotic stewardship. She is a recognized expert in the use of clinical decision support to improve medication utilization in the acute care setting.
“DoseMe and the
At DoseMe, Dr. Kuper will work closely with health systems as she continues to grow the body of literature on precision dosing and lead DoseMe’s
“Kristi is passionate and understands medication safety and antimicrobial stewardship in the acute care setting, in a way few executives can hope to,” said
“We are honored to have another experienced clinical pharmacist join the
Dr. Kuper has served on a number of committees, including the
Dr. Kuper received her Doctor of Pharmacy from the
DoseMe is a
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the
T: (215) 870-0829
BobEast or AsherDewhurst
T: (443) 213-0500
Source: Tabula Rasa HealthCare, Inc.